Streetbeat News

Products Services

NAOV

NanoVibronix, Inc. (Nasdaq: NAOV) announced that its UroShield actuators are eligible for reimbursement on NHS Prescription Services' Drug Tariff effective November 1. The company has received a stocking order from its U.K. distribution partner, Peak Medical Limited, in anticipation of increased demand. The Drug Tariff provides for full reimbursement of UroShield actuators by the NHS, allowing clinicians to prescribe the products.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:36 pm

BRAG

ENTL

Bragg Gaming Group Inc. (BRAG) has extended its agreement with Entain Plc (ENTL) to supply Entain's Dutch iGaming operator, BetCity.nl, with Bragg's Player Account Management (PAM) platform until 2025. Bragg will continue to be the exclusive supplier of content and product delivery services to BetCity.nl. The agreement also includes the integration of several new iGaming suppliers to enhance the localized content portfolio for the Netherlands market.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:35 pm

VTGN

Vistagen (NASDAQ:VTGN) will present positive top-line results from its fasedienol (PH94B) Phase 3 PALISADE-2 trial in social anxiety disorder (SAD) and PH80 Phase 2A study in women diagnosed with vasomotor symptoms due to menopause at two upcoming scientific conferences in November 2023. The company aims to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system disorders.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:35 pm

OSIS

OSI Systems, Inc. (NASDAQ:OSIS) has announced that its Healthcare division, Spacelabs Healthcare®, received an order worth approximately $3 million to provide patient monitoring solutions and related accessories to a U.S. based hospital. The company will provide Xhibit® Central Stations, Qube® patient monitors, XTR telemetry, and related accessories.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:34 pm

BCAN

BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) announced a new plan of work focusing on its proprietary CRM platform to meet the increased demand for medical cannabis in Israel. This follows recent regulatory reforms allowing cannabis as a first-line treatment, leading to a surge in licensed medical cannabis patients. The company's Benefit CRM helps optimize functions like sales management and asset management. The software development phase will focus on AI elements to increase data collection and analysis. In February 2023, BYND Cannasoft received a full license to trade in medical cannabis products.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:34 pm

QLGN

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) has announced the first patient dosing in the Phase 1a clinical trial of QN-302, a potential treatment for advanced or metastatic solid tumors. The trial is being conducted at START Midwest in Grand Rapids, Michigan. QN-302, a G-Quadruplex (G4)-selective transcription inhibitor, was licensed by Qualigen in January 2021 and received Orphan Drug Designation for the treatment of pancreatic cancer. The company expects to provide an update on the trial's safety and preliminary efficacy in the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:33 pm

BTDR

Bitdeer Technologies Group (NASDAQ:BTDR) announced its unaudited mining and operations updates for October 2023, revealing a 173.4% increase in Bitcoin mined compared to October 2022. The company's Gedu Datacenter in Bhutan contributed to this strong performance, providing a 3.3EH/s hash rate and mining 211 Bitcoins. Bitdeer is also advancing the construction of a 175MW immersion cooling datacenter at its Tydal, Norway mining facility, expected to be completed in 2025.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:32 pm

BEAT

HeartBeam has been granted a US patent for a 12-lead extended wear patch for detecting heart attacks and complex cardiac arrhythmias. The company's stock, BEAT, may be impacted by this news.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:32 pm

HON

WFRD

Weatherford International plc (NASDAQ:WFRD) has signed a memorandum of understanding with Honeywell (NYSE:HON) to deliver a combined CygNet™ SCADA and Honeywell Emissions Management suite for advanced emissions management. The integrated system will facilitate immediate access to essential data, enhance operational efficiency, and help customers achieve decarbonization targets.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:31 pm

SLRX

Salarius Pharmaceuticals has completed an FDA Type B meeting for its Seclidemstat Ewing Sarcoma development program. The meeting is a significant step in the drug's development process.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:30 pm